Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study

Journal:

The BMJ

Published:

2026-03-04

DOI:

10.1136/bmj-2025-086886

Affiliations:

7

Authors:

4

Go to article

Institutions	Authors	Share
VA St. Louis Health Care System, United States of America (USA)	2.066667	0.52
Veterans Research and Education Foundation of Saint Louis, United States of America (USA)	1.283333	0.32
Washington University in St. Louis (WUSTL), United States of America (USA)	0.650000	0.16

Interested in Clinical Sciences?